Endometrial cancer: a review and current management strategies: part II

WM Burke, J Orr, M Leitao, E Salom, P Gehrig… - Gynecologic …, 2014 - Elsevier
Endometrial carcinoma is the most common gynecologic malignancy. A thorough
understanding of the epidemiology, pathophysiology, and management strategies for this …

Management of women with uterine papillary serous cancer: A Society of Gynecologic Oncology (SGO) review☆

DM Boruta II, PA Gehrig, AN Fader, AB Olawaiye - Gynecologic oncology, 2009 - Elsevier
OBJECTIVE: Uterine papillary serous carcinoma (UPSC) is a clinically and pathologically
distinct subtype of endometrial cancer. Although less common than its endometrioid …

Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic …

ME Randall, VL Filiaci, H Muss, NM Spirtos… - Journal of clinical …, 2006 - ascopubs.org
Purpose To compare whole-abdominal irradiation (WAI) and doxorubicin-cisplatin (AP)
chemotherapy in women with stage III or IV endometrial carcinoma having a maximum of 2 …

Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium

WT Creasman, MF Kohler, F Odicino… - Gynecologic …, 2004 - Elsevier
OBJECTIVE: The purpose of this study was to evaluate patients with uterine papillary serous
carcinoma (UPSC), clear cell (CC), and grade 3 endometrioid (G3) surgically stage I …

Minimal uterine serous carcinoma: diagnosis and clinicopathologic correlation

DT Wheeler, KA Bell, RJ Kurman… - The American journal of …, 2000 - journals.lww.com
The clinicopathologic features of uterine serous carcinoma (USC) lacking myometrial
invasion, including its putative precursor lesion endometrial intraepithelial carcinoma (EIC) …

The outcome of stage I–II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma

FD Cirisano Jr, SJ Robboy, RK Dodge, RC Bentley… - Gynecologic …, 2000 - Elsevier
Purpose. The aim of this study was to compare survival and recurrence in clinical and
surgical stage I–II papillary serous (PS), clear cell (CC), and endometrioid (EM) cancers of …

Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy

MG Kelly, DM O'malley, P Hui, J McAlpine, H Yu… - Gynecologic …, 2005 - Elsevier
OBJECTIVE.: Uterine papillary serous carcinoma (UPSC) is an aggressive form of
endometrial cancer characterized by a high recurrence rate and a poor prognosis. Prior …

The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the endometrium

S Nag, B Erickson, S Parikh, N Gupta, M Varia… - International Journal of …, 2000 - Elsevier
Purpose: To develop recommendations for use of high-dose-rate (HDR) brachytherapy in
patients with endometrial cancer. Methods: A panel of members of the American …

Significant pelvic recurrence in high-risk pathologic stage I–IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation …

AJ Mundt, R McBride, J Rotmensch… - International Journal of …, 2001 - Elsevier
Objective: To evaluate the risk of pelvic recurrence (PVR) in high-risk pathologic Stage I–IV
endometrial carcinoma patients after adjuvant chemotherapy alone. Methods: Between …

Rare uterine cancers

S Acharya, ML Hensley, AC Montag… - The lancet oncology, 2005 - thelancet.com
The most common malignant tumour of the uterus is endometrioid endometrial cancer.
However, many less common malignant diseases also develop in the uterus, including both …